Christopher Missling - Aug 2, 2021 Form 4 Insider Report for ANAVEX LIFE SCIENCES CORP. (AVXL)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher Missling
Stock symbol
AVXL
Transactions as of
Aug 2, 2021
Transactions value $
$0
Form type
4
Date filed
8/4/2021, 05:19 PM
Previous filing
Jul 1, 2021
Next filing
Jun 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVXL Stock Option (Right to Buy) Award $0 +500K $0.00 500K Aug 2, 2021 Common Stock 500K $18.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest upon achieving a key enrollment milestone in a late stage clinical study.